Cargando…

The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers

OBJECTIVE: An interferon-gamma release assay (IGRA) is used to screen for latent tuberculosis infection (LTBI). Among IGRAs, the QuantiFERON-TB Gold In-Tube (QFT-GIT) results are highly variable, so the borderline zone has been proposed to reduce unnecessary LTBI treatment. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jae Hyeon, Kim, Namhee, Park, Hyunwoong, Kim, Taek Soo, Park, Sang-Won, Roh, Eun Youn, Yoon, Jong Hyun, Shin, Sue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326217/ https://www.ncbi.nlm.nih.gov/pubmed/32603343 http://dx.doi.org/10.1371/journal.pone.0235254

Ejemplares similares

Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs
por: Yun, Jiwon, et al.
Publicado: (2021)

Serial interferon-gamma release assays during treatment of active tuberculosis in young adults
por: Lee, Sei Won, et al.
Publicado: (2010)

Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workers
por: Nienhaus, Albert, et al.
Publicado: (2013)

Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population
por: Lee, Seung Heon, et al.
Publicado: (2015)

Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011)

Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea: Korean HPV18 variants and clinical manifestation
por: Kim, Namhee, et al.
Publicado: (2020)

Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
por: Kim, Namhee, et al.
Publicado: (2021)

Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay
por: Shu, Chin-Chung, et al.
Publicado: (2016)

The Usefulness of Interferon-gamma Release Assay for Diagnosis of Tuberculosis-related Uveitis in Korea
por: Ahn, Seong Joon, et al.
Publicado: (2014)

Differences in the diagnosis and treatment of hematologic malignancies attributable to health insurance coverage
por: Song, Eun Young, et al.
Publicado: (2022)

Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review
por: Ringshausen, Felix C, et al.
Publicado: (2012)

Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis
por: Mitchell, Jordan L., et al.
Publicado: (2021)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
por: Park, Heechul, et al.
Publicado: (2022)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Evaluation of Five User-Friendly Whole Genome Sequencing Software for Mycobacterium tuberculosis in Clinical Application
por: Kim, Namhee, et al.
Publicado: (2022)

Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes
por: Park, Jae Hyeon, et al.
Publicado: (2022)

Interferon-Gamma Release Assay in a Patient with Tuberculosis Verrucosa Cutis
por: Kim, Geon, et al.
Publicado: (2015)

Serial testing with an interferon-γ release assay in German healthcare workers
por: Schablon, Anja, et al.
Publicado: (2010)

Serial testing with the interferon-γ release assay in Portuguese healthcare workers
por: Torres Costa, José, et al.
Publicado: (2010)

Performance of whole-blood interferon-gamma release assay in patients admitted to the emergency department with pulmonary infiltrates
por: Lee, Yoon Jee, et al.
Publicado: (2011)

Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays
por: Bedini, A., et al.
Publicado: (2016)

Enhancing the interferon-γ release assay through omission of nil and mitogen values
por: Jung, Yun Jung, et al.
Publicado: (2023)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Comparison of the Tuberculin Skin Test and Interferon Gamma Release Assay for the Screening of Tuberculosis in Adolescents in Close Contact with Tuberculosis TB Patients
por: Song, Seung-Eun, et al.
Publicado: (2014)

Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection
por: Kang, Yun-Jeong, et al.
Publicado: (2021)

Factors associated with non-initiation of latent tuberculosis treatment among healthcare workers with a positive interferon-gamma releasing assay
por: Lee, Hyun, et al.
Publicado: (2019)

The First Case of Azorhizobium caulinodans Bacteremia in a Patient with Leukemia
por: Park, Jae Hyeon, et al.
Publicado: (2022)

The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014)

Latent Tuberculosis Infection Screening and Treatment in Congregate Settings (TB FREE COREA): Demographic Profiles of Interferon-Gamma Release Assay Cohort
por: Kim, Hyung Woo, et al.
Publicado: (2021)

Performance Evaluation of a New Automated Chemiluminescent Immunoanalyzer-Based Interferon-Gamma Releasing Assay AdvanSure I3 in Comparison With the QuantiFERON-TB Gold In-Tube Assay
por: Kim, Jin Ju, et al.
Publicado: (2020)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022)

Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population
por: Yang, Ying, et al.
Publicado: (2022)

622. Development of Interferon-Gamma Release Assays for Diagnosing Latent Talaromycosis
por: Xu, Helen, et al.
Publicado: (2023)

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?
por: Jung, Jaewan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ru93u0psgir471u5s58ca608ck